Verition Fund Management LLC Replimune Group, Inc. Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 23,328 shares of REPL stock, worth $274,803. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,328
Previous 34,948
33.25%
Holding current value
$274,803
Previous $383,000
26.37%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding REPL
# of Institutions
161Shares Held
74.9MCall Options Held
38.4KPut Options Held
43.7K-
Baker Bros. Advisors LP New York, NY11MShares$130 Million1.48% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$129 Million0.02% of portfolio
-
Redmile Group, LLC San Francisco, CA4.91MShares$57.8 Million4.65% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$55.5 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.97MShares$46.8 Million8.12% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $581M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...